Stay updated on Atorvastatin for Cavernous Angioma Hemorrhage Clinical Trial
Sign up to get notified when there's something new on the Atorvastatin for Cavernous Angioma Hemorrhage Clinical Trial page.

Latest updates to the Atorvastatin for Cavernous Angioma Hemorrhage Clinical Trial page
- Check2 days agoChange DetectedThe page's revision history now lists Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor update to the document's version labeling.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s revision/version footer label has been updated from v3.5.2 to v3.5.3, indicating a website release rather than a change to the ClinicalTrials.gov study information.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded the final JAHA publication citation for Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations after Discontinuation of Atorvastatin or Placebo (Ali et al., 2026; JAHA 15(3):e46943) with publication date Feb 3, 2026 and DOI. Replaced the previous online-ahead-of-print entry with the final publication record (v3.4.3).SummaryDifference0.1%

- Check95 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing the previous Revision: v3.4.1. This appears to be a minor update to the page's revision label with no change to the study details.SummaryDifference0.1%

Stay in the know with updates to Atorvastatin for Cavernous Angioma Hemorrhage Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atorvastatin for Cavernous Angioma Hemorrhage Clinical Trial page.